Clinical Trial Update: Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of Tor Kinase Inhibitor in Liver Cancer Patients [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, pharmacokinetics and preliminary efficacy of a Tor Kinase Inhibitor in patients with advanced hepatocellular carc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Tor Kinase Inhibitor

Snippet

Sponsor: AstraZeneca | Conditions: Cancer, Advanced Hepatocellular Carcinoma | Phase 1 | Status: COMPLETED